Show simple item record

dc.contributor.authorJayawardena, H. Surangi N.
dc.contributor.authorJayawardana, Kalana W.
dc.contributor.authorChen, Xuan
dc.contributor.authorYan, Mingdi
dc.date2022-08-11T08:08:13.000
dc.date.accessioned2022-08-23T15:46:45Z
dc.date.available2022-08-23T15:46:45Z
dc.date.issued2013-05-08
dc.date.submitted2013-07-15
dc.identifier.doi10.13028/czk1-4r20
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27825
dc.description.abstractNanoparticles conjugated with D-maltoheptaose (G7) showed a striking increase in the surface adherence and internalization by E. coli. This applies to silica nanoparticles (SNP), magnetic nanoparticles (MNP), silica-coated magnetic nanoparticles (SMNP) and silica-coated quantum dots (SQDs) ranging from a few to over a hundred nanometers in size, as well as wild type E. coli ATCC 33456, ORN 178, ORN 208 with the maltodextrin transport channel and the LamB mutant JW 3392-1 (Fig. 1). TEM images including the thin section samples revealed the uptake of nanoparticles in cell walls and inside the cytoplasm (Fig. 2). Unfunctionalized nanoparticles and nanoparticles functionalized with β-cyclodextrin (CD) showed little or no binding to the E. coli cell surface, and no obvious internalization of the nanoparticles was observed. D-Mannose-functionalized nanoparticles bound to the pili of E. coli ORN 178 through the well-known Man-binding lectin (FimH) rather than cell internalization. Surface ligands that can improve the uptake of nanomaterials to bacterial cells should provide a powerful means of targeting a payload delivery to a potential disease causing strain. Work is underway to develop nanomaterial delivery systems for multidrug resistance bacteria.
dc.formatyoutube
dc.language.isoen_US
dc.rightsCopyright the Author(s)
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/
dc.subjectBiochemistry
dc.subjectChemistry
dc.subjectNanoscience and Nanotechnology
dc.subjectTherapeutics
dc.subjectTranslational Medical Research
dc.titleMaltoheptaose Promotes Nanoparticle Internalization by Escherichia coli
dc.typePoster Abstract
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1137&context=cts_retreat&unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/cts_retreat/2013/posters/44
dc.identifier.contextkey4313682
refterms.dateFOA2022-08-23T15:46:46Z
html.description.abstract<p>Nanoparticles conjugated with D-maltoheptaose (G7) showed a striking increase in the surface adherence and internalization by E. coli. This applies to silica nanoparticles (SNP), magnetic nanoparticles (MNP), silica-coated magnetic nanoparticles (SMNP) and silica-coated quantum dots (SQDs) ranging from a few to over a hundred nanometers in size, as well as wild type E. coli ATCC 33456, ORN 178, ORN 208 with the maltodextrin transport channel and the LamB mutant JW 3392-1 (Fig. 1). TEM images including the thin section samples revealed the uptake of nanoparticles in cell walls and inside the cytoplasm (Fig. 2). Unfunctionalized nanoparticles and nanoparticles functionalized with β-cyclodextrin (CD) showed little or no binding to the E. coli cell surface, and no obvious internalization of the nanoparticles was observed. D-Mannose-functionalized nanoparticles bound to the pili of E. coli ORN 178 through the well-known Man-binding lectin (FimH) rather than cell internalization. Surface ligands that can improve the uptake of nanomaterials to bacterial cells should provide a powerful means of targeting a payload delivery to a potential disease causing strain. Work is underway to develop nanomaterial delivery systems for multidrug resistance bacteria.</p>
dc.identifier.submissionpathcts_retreat/2013/posters/44


Files in this item

Thumbnail
Name:
Jayawardena__2_.pdf
Size:
147.9Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright the Author(s)
Except where otherwise noted, this item's license is described as Copyright the Author(s)